Cervical cancer is the leading cause of cancer death for women in developing countries. Three out of every four new cases of cervical cancer each year are in developing countries that lack screening and treatment programs which might catch the pre-cancerous lesions before they become invasive and lead to a long and painful death. The PAP smear, a cytology-based screening, is largely unavailable in developing countries. However, a quick and easy low-tech method for visual inspection with acetic acid (VIA) has been carefully developed and tested. Research suggests that local health-care professionals can easily apply the acetic acid, visually inspect the cervix, and accurately diagnose the pre... read more Cervical cancer is the leading cause of cancer death for women in developing countries. Three out of every four new cases of cervical cancer each year are in developing countries that lack screening and treatment programs which might catch the pre-cancerous lesions before they become invasive and lead to a long and painful death. The PAP smear, a cytology-based screening, is largely unavailable in developing countries. However, a quick and easy low-tech method for visual inspection with acetic acid (VIA) has been carefully developed and tested. Research suggests that local health-care professionals can easily apply the acetic acid, visually inspect the cervix, and accurately diagnose the presence of pre-cancerous lesions which can then be successfully treated with cryotherapy. The cervical cancer epidemic is preventable and needs to end. Cure Cervical Cancer (CCC) is dedicated to the early detection, treatment, and cure of cervical cancer. We do this by establishing sustainable, ongoing cervical cancer "See and Treat" clinics.
Each of GlobalGiving’s nonprofit partners is required to send quarterly donor reports detailing the impact of their work.
